Influenza A Virus-Driven Airway Inflammation may be Dissociated From Limb Muscle Atrophy in Cigarette Smoke-Exposed Mice.

COPD conditioned medium fiber type transformation lung-to-muscle axis muscle weakness myogenic disruption viral exacerbation

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2022
Historique:
received: 21 01 2022
accepted: 17 02 2022
entrez: 4 4 2022
pubmed: 5 4 2022
medline: 5 4 2022
Statut: epublish

Résumé

Limb muscle dysfunction is a hallmark of Chronic Obstructive Pulmonary Disease (COPD) which is further worsened following a viral-induced acute exacerbation of COPD (AECOPD). An amplified airway inflammation underlies the aggravated respiratory symptoms seen during AECOPD, however, its contributory role to limb muscle dysfunction is unclear. The present study examined the impact of influenza A virus (IAV)-induced exacerbation on hind limb muscle parameters. Airway inflammation was established in male BALB/c mice by exposure to cigarette smoke (CS) for 8 weeks. Exacerbation was then induced via inoculation with IAV, and various lung and muscle parameters were assessed on day 3 (peak of airway inflammation) and day 10 (resolution phase) post-infection. IAV infection exacerbated CS-induced airway inflammation as evidenced by further increases in immune cell counts within bronchoalveolar lavage fluid. Despite no significant impact on muscle mass, IAV exacerbation worsened the force-generating capacity of the tibialis anterior (TA) muscle. Protein oxidation and myogenic disruption was observed in the TA following CS exposure, however, IAV exacerbation did not augment these detrimental processes. To further explore the contributory role of airway inflammation on myogenic signaling, cultured myotubes were exposed to conditioned medium (CM) derived from bronchial epithelial cells stimulated with polyinosinic:polycytidylic acid and cigarette smoke extract (CSE). Despite an amplified inflammatory response in the lung epithelial cells, the CM derived from these cells did not potentiate myogenic disruption in the C2C12 myotubes. In conclusion, our data suggest that certain parameters of limb muscle dysfunction seen during viral-induced AECOPD may be independent of airway inflammation.

Identifiants

pubmed: 35370652
doi: 10.3389/fphar.2022.859146
pii: 859146
pmc: PMC8971713
doi:

Types de publication

Journal Article

Langues

eng

Pagination

859146

Informations de copyright

Copyright © 2022 Mou, Chan, Brassington, Dobric, De Luca, Seow, Selemidis, Bozinovski and Vlahos.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Chron Obstruct Pulmon Dis. 2021 Jan 07;16:25-40
pubmed: 33442246
Eur J Clin Nutr. 2020 Nov;74(11):1556-1564
pubmed: 32296123
J Virol. 1997 Nov;71(11):8204-12
pubmed: 9343171
Am J Respir Crit Care Med. 2016 Mar 15;193(6):696-8
pubmed: 26977971
Thorax. 2020 Jun;75(6):520-527
pubmed: 32217784
Pol Arch Med Wewn. 2014;124(7-8):403-9
pubmed: 24881626
Am J Respir Crit Care Med. 2012 Apr 15;185(8):825-34
pubmed: 22312013
Am J Clin Nutr. 2005 Jul;82(1):53-9
pubmed: 16002800
Am J Respir Crit Care Med. 2002 Sep 15;166(6):809-13
pubmed: 12231489
Respir Res. 2008 Jul 15;9:53
pubmed: 18627612
Cell Metab. 2009 Dec;10(6):507-15
pubmed: 19945408
Eur Respir J. 2009 May;33(5):1165-85
pubmed: 19407051
Lancet Respir Med. 2013 Mar;1(1):73-83
pubmed: 24321806
Int J Mol Sci. 2021 Aug 16;22(16):
pubmed: 34445491
J Leukoc Biol. 2017 Apr;101(4):863-874
pubmed: 27707881
Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):935-40
pubmed: 22215599
Sci Rep. 2017 Oct 25;7(1):14000
pubmed: 29070788
Arch Phys Med Rehabil. 2005 Oct;86(10):1979-85
pubmed: 16213242
PLoS One. 2014 Jan 10;9(1):e84855
pubmed: 24427297
Clin Sci (Lond). 2017 Jul 1;131(13):1541-1558
pubmed: 28659395
Respir Med. 2010 Mar;104(3):378-88
pubmed: 19932014
Eur Respir Rev. 2010 Jun;19(116):113-8
pubmed: 20956179
Expert Rev Clin Immunol. 2013 Nov;9(11):1055-68
pubmed: 24168412
Respir Res. 2020 Jul 8;21(1):176
pubmed: 32641167
Eur Respir J. 2001 Jun;17(6):1112-9
pubmed: 11491152
Sci Rep. 2016 Feb 15;6:20983
pubmed: 26877172
Am J Physiol Lung Cell Mol Physiol. 2006 May;290(5):L931-45
pubmed: 16361358
Am J Respir Crit Care Med. 2004 Oct 15;170(8):870-8
pubmed: 15271690
Nat Rev Immunol. 2018 Jul;18(7):454-466
pubmed: 29626211
J Cell Mol Med. 2017 Jan;21(1):130-141
pubmed: 27619557
Pharmacol Ther. 2015 Nov;155:60-79
pubmed: 26297673
Am J Respir Crit Care Med. 2006 May 15;173(10):1114-21
pubmed: 16484677
Eur Respir J. 2007 Mar;29(3):527-34
pubmed: 17107990
Elife. 2014 Jul 22;3:e03496
pubmed: 25053742
Immunol Allergy Clin North Am. 2013 Feb;33(1):95-115
pubmed: 23337067
Am J Respir Crit Care Med. 2014 May 1;189(9):e15-62
pubmed: 24787074
Am J Physiol Endocrinol Metab. 2003 Mar;284(3):E481-7
pubmed: 12419777
Am J Respir Cell Mol Biol. 2020 Feb;62(2):217-230
pubmed: 31461300
Sci Rep. 2019 Nov 27;9(1):17732
pubmed: 31776393
Clin Sci (Lond). 2014 Feb;126(4):253-65
pubmed: 24144354
Respiration. 2019;97(4):302-309
pubmed: 30481791
Am J Respir Crit Care Med. 2015 Oct 1;192(7):810-6
pubmed: 26068143
J Immunol. 2019 Jan 15;202(2):484-493
pubmed: 30530483
Respir Res. 2018 Nov 9;19(1):218
pubmed: 30413158
J Cell Sci. 2014 Dec 15;127(Pt 24):5204-17
pubmed: 25380823
Expert Rev Respir Med. 2021 Jan;15(1):103-115
pubmed: 33131350
Am J Respir Cell Mol Biol. 2013 May;48(5):531-9
pubmed: 23328639
Mucosal Immunol. 2021 Jul;14(4):815-827
pubmed: 33758367
Am J Respir Crit Care Med. 2010 Aug 15;182(4):477-88
pubmed: 20413628
Ann Nutr Metab. 2009;54(1):52-8
pubmed: 19252400
Lancet Respir Med. 2016 Nov;4(11):911-924
pubmed: 27264777
Thorax. 2007 Nov;62(11):944-9
pubmed: 17526675
Int J Sports Med. 2006 Feb;27(2):94-9
pubmed: 16475053
Pharmacol Ther. 2016 Oct;166:56-70
pubmed: 27373503
Am J Respir Crit Care Med. 1996 Mar;153(3):976-80
pubmed: 8630582
Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582
pubmed: 28128970
Br J Pharmacol. 2021 Aug;178(15):3049-3066
pubmed: 33817783
Eur Respir J. 2012 Oct;40(4):851-62
pubmed: 22408199
Am J Respir Crit Care Med. 1998 Aug;158(2):629-34
pubmed: 9700144

Auteurs

Kevin Mou (K)

School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.

Stanley M H Chan (SMH)

School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.

Kurt Brassington (K)

School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.

Aleksandar Dobric (A)

School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.

Simone N De Luca (SN)

School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.

Huei Jiunn Seow (HJ)

School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.

Stavros Selemidis (S)

School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.

Steven Bozinovski (S)

School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.

Ross Vlahos (R)

School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.

Classifications MeSH